These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34052685)

  • 1. Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends.
    Meisel SN; Treloar Padovano H; Miranda R
    Drug Alcohol Depend; 2021 Aug; 225():108747. PubMed ID: 34052685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Day-level shifts in social contexts during youth cannabis use treatment.
    Meisel SN; Carpenter RW; Treloar Padovano H; Miranda R
    J Consult Clin Psychol; 2021 Apr; 89(4):251-263. PubMed ID: 34014688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
    Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
    Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users.
    Treloar Padovano H; Miranda R
    J Stud Alcohol Drugs; 2018 Mar; 79(2):190-198. PubMed ID: 29553345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial.
    Emery NN; Carpenter RW; Meisel SN; Miranda R
    Psychopharmacology (Berl); 2021 Nov; 238(11):3095-3106. PubMed ID: 34331080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does sleep relate to next-day cannabis use during treatment? Findings from an adolescent and young adult motivational enhancement and cognitive behavioral therapy plus topiramate intervention.
    Parnes JE; Berey BL; Pielech M; Meisel SN; Padovano HT; Miranda R
    Drug Alcohol Depend; 2023 Dec; 253():111006. PubMed ID: 37944198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Gray JC; Treloar Padovano H; Wemm SE; Miranda R
    J Clin Psychopharmacol; 2018 Apr; 38(2):134-137. PubMed ID: 29424802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley JD
    Psychiatr Clin North Am; 2023 Dec; 46(4):775-788. PubMed ID: 37879838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging Youth (Adolescents and Young Adults) to Change Frequent Marijuana Use: Motivational Enhancement Therapy (MET) in Primary Care.
    Kells M; Burke PJ; Parker S; Jonestrask C; Shrier LA
    J Pediatr Nurs; 2019; 49():24-30. PubMed ID: 31473464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
    Cooper K; Chatters R; Kaltenthaler E; Wong R
    Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series.
    Trigo JM; Soliman A; Staios G; Quilty L; Fischer B; George TP; Rehm J; Selby P; Barnes AJ; Huestis MA; Le Foll B
    J Addict Med; 2016; 10(4):274-9. PubMed ID: 27261670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A test of competing mediators linking trouble sleeping to cannabis use in adolescents and emerging adults.
    Berey BL; Meisel S; Pielech M; Parnes JE; Treloar Padovano H; Miranda R
    Exp Clin Psychopharmacol; 2024 Jun; 32(3):316-328. PubMed ID: 38127518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetitive startle modulation in the human laboratory predicts Cannabis craving in the natural environment.
    Mereish EH; Padovano HT; Wemm S; Miranda R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1933-1943. PubMed ID: 29623354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary test of a brief intervention to lessen young adults' cannabis use: Episode-level smartphone data highlights the role of protective behavioral strategies and exercise.
    Prince MA; Collins RL; Wilson SD; Vincent PC
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):150-156. PubMed ID: 31144836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.
    Buckner JD; Zvolensky MJ; Crosby RD; Wonderlich SA; Ecker AH; Richter A
    Drug Alcohol Depend; 2015 Feb; 147():20-5. PubMed ID: 25578250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Momentary Mindfulness With Affect and Cannabis Desire in a Trial of Cannabis Use Interventions With and Without Momentary Assessment.
    Shrier LA; Harris SK
    J Adolesc Health; 2023 Jan; 72(1):126-129. PubMed ID: 36272891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.